Schwegman, Lundberg & Woessner - Intellectual Property Attorneys
Client Log-In


Search The Site
Our Firm
Attorneys
Join Us - Life at SLWK
IP Resource Center
Education/Training
What's New
FAQs
Contact Us
Client Log-In
Ranked First In Patent Quality - Learn More
Attorneys - Representative Patents

Attorneys - Alphabetical Listing

Attorneys By Practice Area

 Content page upper right links


Representative Issued Patents Drafted by Albin James Nelson

  • U.S. Patent 4,036,853 “Semisynthetic Oleandomycin Derivatives C8 Modifications”

  • U.S. Patent 4,092,349 “11-Desoxy – 15-Thiaprostaglandins”

  • U.S. Patent 4,097,601 “Bone Deposition by 2-Descarboxyl-2-(Tetrazol-5yl)-11-Desoxy-16Aryl Prostaglandins”

  • U.S. Patent 4,177,346 “1,5-Disubstituted -2-Pyrrolidone Prostglandins”

  • U.S. Patent 4,181,729 “Phenyl or Phenoxy Substituted Spiroimidazolidinedione Derivatives”

  • U.S. Patent 4,211,794 “N, N-Disubstituted Aminomethylphenylethanolamines”

  • U.S. Patent 4,638,005 “Monoquaternized Pyrazinium Compounds and Their Use as Electron Carriers In Photosynthetic Processes”

  • U.S. Patent 4,791,168 “Polyurethane Resins in Water-Dilutable Basecoats Having Low Flash and Quick-Drying Characteristics”

  • U.S. Patent 4,824,927 “Products of Diepoxide Polyaddition With Monofunctional Initiators”

  • U.S. Patent 4,857,567 “Flexible Aryl, Alkyl Epoxy Resins, Their Amine Resin Derivatives and Their Use in Electrodeposition”

  • U.S. Patent 5,015,477 “Edible, Baked Composition Containing Cholestyramine”

  • U.S. Patent 5,225,608 “Sandalwood Odorants”

  • U.S. Patent 5,279,954 “Exopeptidase Catylized Site-Specific Bonding of Supports, Labels and Bioactive Agents to Proteins”

  • U.S. Patent 5,527,840 “Aqueous Coating Composition”

  • U.S. Patent 5,595,887 “Purification Directed Cloning of Peptides Using Carbonic Anhydrase as the Affinity Binding Segment”

  • U.S. Patent 5,739,176 “Biodegradable In-Situ Forming Implants and Methods of Producing Same”

  • U.S. Patent 5,807,924 “Coating Media and a Process for Producing Multi-Layer Coatings”

  • U.S. Patent 5,945,115 “Polymeric Compositions Useful as Controlled Release Implants”

  • U.S. Patent 6,071,530 “Method and Composition for Treating a Bone Tissue Defect”

  • U.S. Patent 6,127,150 “Purification Cloning of Peptides”

  • U.S. Patent 6,143,314 “Controlled Release Liquid Delivery Composition with Low Initial Drug Burst”

  • U.S. Patent 6,261,583 “Moldable Solid Delivery System”

  • U.S. Patent 6,287,814 “RNA Export Element and Methods of Use”

  • U.S. Patent 6,312,908 “Method for Isolation of Extrachromosomal Amplified Genes”

  • U.S. Patent 6,312,912 “Method for Identifying a Cis-Acting RNA Export Element”

  • U.S. Patent 6,537,565 “Filamentous Porous Films and Methods for Producing Same for Bilogical Implants”

  • U.S. Patent 6,565,874 “Polymeric Delivery Formulations of Leuprolide with Improved Efficacy”

  • U.S. Patent 6,783,946 “Positively Charged Non-Natural Amino Acids, Methods of Making Thereof and Use Thereof in Peptides”

  • U.S. Patent 6,951,947 “Labeled Peptides, Proteins and Antibodies and Process and Intermediates Useful For Their Preparation”

Printable Format
SLW has obtained over 3,000 patents in its first ten years.



Our Firm   Attorneys   Join Us - Life at SLW   IP Resource Center   Education/Training   What's New   FAQs   Contact Us   Client Log-In   Home

© 2008 Schwegman, Lundberg & Woessner, P.A. All Rights Reserved.